Trastuzumab is a monoclonal antibody targeted against the human epidermal growth factor receptor (HER) 2 tyrosine kinase receptor, which is overexpressed in approximately 25% of invasive breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback